单位：[1]Sana Hospital Lichtenberg, Medical Department I/Gastroenterology, Berlin, Germany[2]Department Allgemeine Innere Medizin, Kliniken Hirslanden, Beau Site, Salem und Permanence, Bern, Switzerland[3]Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria[4]Center of Ultrasound Diagnostics, University Hospital Giessen and Marburg, Philipps University Marburg, Baldingerstraße, Marburg, Germany[5]Krankenhaus Märkisch-Oderland, Department of Internal Medicine, Strausberg, Germany Brandenburg Institute for Clinical Ultrasound (BICUS) at Medical University Brandenburg, Neuruppin, Germany[6]Medical Department, Helios Klinikum Meiningen, Germany[7]Interventional, Diagnostic and Therapeutic Ultrasound Unit, Department of Medical and Surgical Sciences, IRCCS, Azienda Ospedaliero-Universitaria Sant’Orsola Malpighi Hospital, Bologna, Italy[8]Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China[9]Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China超声影像科华中科技大学同济医学院附属同济医院[10]Imaging Department, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK[11]Rems-Murr-Klinikum, Winnenden, Germany[12]Inselspital, University Hospital
In this series of articles with comments and illustrations on the World Federation for Medicine and Biology (WFUMB) guidelines on contrast-enhanced ultrasound (CEUS) the topics of very rare focal liver lesions (FLL) are discussed. Improving the detection and characterization of the most common FLL are the main topics of these guidelines. The focus of this review is on the many manifestations of cystic fibrosis-related liver disease (CFLD). These include focal biliary fibrosis, liver cirrhosis, vascular manifestations with nodular regenerative hyperplasia and portal hypertension with or without cirrhosis. This article describes the diverse changes of liver involvement in cystic fibrosis and their appearance on ultrasound, duplex sonography, and contrast enhanced ultrasonography. This knowledge and the imaging should help to recognize liver manifestations in time and enable a correct interpretation of ultrasound images in CF in the corresponding clinical situation.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|4 区医学
小类|4 区声学4 区核医学
最新[2025]版：
大类|4 区医学
小类|4 区声学4 区核医学
第一作者：
第一作者单位：[1]Sana Hospital Lichtenberg, Medical Department I/Gastroenterology, Berlin, Germany
通讯作者：
推荐引用方式(GB/T 7714)：
Kathleen Möller,Friedrich Thomas,Safai Zadeh Ehsan,et al.Comments and illustrations of the WFUMB CEUS liver guidelines: Cystic fibrosis associated liver disease[J].Medical ultrasonography.2023,doi:10.11152/mu-4297.
APA：
Kathleen Möller,Friedrich Thomas,Safai Zadeh Ehsan,Christian Görg,Jenssen Christian...&Dietrich Christoph F.(2023).Comments and illustrations of the WFUMB CEUS liver guidelines: Cystic fibrosis associated liver disease.Medical ultrasonography,,
MLA：
Kathleen Möller,et al."Comments and illustrations of the WFUMB CEUS liver guidelines: Cystic fibrosis associated liver disease".Medical ultrasonography .(2023)
